Chih-Hsiung Kang
Papers
1
Total Citations
11
H-Index
1
About
Dr. Chih-Hsiung Kang is a leading urological surgeon whose research focuses on advancing minimally invasive treatments for renal tumours, with particular expertise in robot-assisted and ablative techniques. His major contributions center on comparing the long-term efficacy and renal function preservation of robot-assisted laparoscopic partial nephrectomy (RaPN) versus laparoscopic cryoablation for localized renal neoplasms. In his landmark 2021 study, Dr. Kang conducted a rigorous propensity score-matched analysis of long-term outcomes, demonstrating that while cryoablation remains recommended for clinical T1a stage tumours, RaPN offers superior oncological control with comparable renal function preservation. This work, cited 11 times, provides critical evidence guiding surgical decision-making for patients with renal cell carcinoma. Dr. Kang’s research directly addresses the delicate balance between cancer control and nephron-sparing goals, helping to refine treatment algorithms for localized disease. His comparative effectiveness studies have influenced clinical practice by clarifying which patients benefit most from each approach, ultimately improving personalized surgical planning and long-term outcomes for kidney cancer patients.
Research Focus
Key Achievements
Top Papers
- 1